Kytopen announces expansion of its partnership program into Europe with its agreement with T-CURX GmbH, a biotech company based in Würzburg, Germany. T-CURX, a clinically focused therapeutic company developing personalized immunotherapies, will have on-site access to Kytopen’s Flowfect…